Nextage Therapeutics (Israel) Price on November 18, 2024
| MCTC Stock | ILA 73.30 1.60 2.14% |
If you're considering investing in Nextage Stock, it is important to understand the factors that can impact its price. As of today, the current price of Nextage Therapeutics stands at 73.30, as last reported on the 14th of December 2024, with the highest price reaching 74.50 and the lowest price hitting 73.30 during the day. Nextage Therapeutics appears to be very steady, given 3 months investment horizon. Nextage Therapeutics has Sharpe Ratio of 0.0548, which conveys that the firm had a 0.0548% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Nextage Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Nextage Therapeutics' Downside Deviation of 4.9, mean deviation of 4.29, and Risk Adjusted Performance of 0.074 to check out if our risk estimates are consistent with your expectations.
Nextage Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Nextage |
Sharpe Ratio = 0.0548
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MCTC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.55 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.25 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Nextage Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nextage Therapeutics by adding it to a well-diversified portfolio.
Nextage Therapeutics Valuation on November 18, 2024
It is possible to determine the worth of Nextage Therapeutics on a given historical date. On November 18, 2024 Nextage was worth 73.3 at the beginning of the trading date compared to the closed value of 74.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Nextage Therapeutics stock. Still, in general, we apply an absolute valuation method to find Nextage Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nextage Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Nextage Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 70.40 | 74.50 | 70.00 | 74.50 | 30,630 | |
11/18/2024 | 73.30 | 74.50 | 73.30 | 74.50 | 13,223 |
| 74.50 | 89.70 | 74.50 | 84.00 | 462,833 |
| Backtest Nextage Therapeutics | | | Nextage Therapeutics History | | | Nextage Therapeutics Valuation | Previous | Next |
Nextage Therapeutics Trading Date Momentum on November 18, 2024
| On November 19 2024 Nextage Therapeutics was traded for 84.00 at the closing time. The highest price during the trading period was 89.70 and the lowest recorded bid was listed for 74.50 . The volume for the day was 462.8 K. This history from November 19, 2024 contributed to the next trading day price jump. The trading delta at closing time to the next closing price was 12.75% . The trading delta at closing time to the current price is 11.54% . |
Nextage Therapeutics Fundamentals Correlations and Trends
By evaluating Nextage Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Nextage Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Nextage financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Nextage Therapeutics Stock history
Nextage Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nextage is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nextage Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nextage Therapeutics stock prices may prove useful in developing a viable investing in Nextage Therapeutics
Micromedic Technologies Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. Further, the company provides diagnostic solutions for multiple cancer diagnostic applications. MICROMEDIC TECHNOL operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange.
Nextage Therapeutics Stock Technical Analysis
Nextage Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Nextage Therapeutics Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
Nextage Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Nextage Therapeutics December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how Nextage Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nextage Therapeutics shares will generate the highest return on investment. By undertsting and applying Nextage Therapeutics stock market strength indicators, traders can identify Nextage Therapeutics entry and exit signals to maximize returns
Nextage Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Nextage Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Nextage Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Nextage to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.074 | |||
| Jensen Alpha | 0.4373 | |||
| Total Risk Alpha | (0.23) | |||
| Sortino Ratio | 0.0964 | |||
| Treynor Ratio | 0.4045 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Nextage Stock analysis
When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |